HPV detection rate in discordant Pap tests between cytotechnologists and pathologists

Diagnostic Cytopathology

Volumn 37, Issue 5, 2009, Pages 320-323

  Chhieng, David C ^a   Bakdounes, K ^b   Connolly, Mary ^b   Gallaspy, Sandra ^b   Roberson, Janie ^b   Eltoum, Isam ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Atypical squamous cells; Discordance; Human papilloma virus

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; CYTOTECHNOLOGIST; DNA VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN CELL; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL; VIRUS DETECTION; WART VIRUS;

CYTOLOGY; DIAGNOSTIC ERRORS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; OBSERVER VARIATION; PAPILLOMAVIRIDAE; PATHOLOGY, CLINICAL; VAGINAL SMEARS;

EID: 66349119697     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20977     Document Type: Article

References (14)

1. Krieger PA. Strategies for reducing Papanicolaou smear screening errors: Principles derived from data and experience with quality control. Arch Pathol Lab Med 1997;121:277-281. (Pubitemid 27118238)
2. Chhieng DC, Chen J, Connolly K, Roberson J, Eltoum I. High-risk HPV DNA detection rate in patients with atypical squamous cells and its relationship to the atypical squamous cell: Squamous intraepithelial lesion ratio. Acta Cytol 2006;50:291-294. (Pubitemid 43837041)
3. Sherman ME, Schiffman MH, Lorincz AT, Manos MM, Scott DR, Kuman RJ, Kiviat NB, Stoler M, Glass AG, Rush BB. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994;102:182-187. (Pubitemid 24320521)
4. Zuna RE, Moore W, Dunn ST. HPV DNA testing of the residual sample of liquid-based Pap test: Utility as a quality assurance monitor. Mod Pathol 2001;14:147-151. (Pubitemid 32246816)
5. Wright TC, Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197:340-345.
6. Medicare MaCP, editor. Regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Washington, D.C.: Federal Register; Vol.57, 1992.
7. Condel JL, Mahood LK, Grzybicki DM, Sturgis CD, Raab SS. Papanicolaou tests diagnosed as atypical by a cytotechnologist and downgraded to benign by a pathologist: A measure of laboratory quality. Am J Clin Pathol 2002;117:534-540. (Pubitemid 34823681)
8. Wright TC, Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; Conference AS-SC. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.
9. Tworek JA, Jones BA, Raab S, Clary KM, Walsh MK. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: A College of American Pathologists Q-Probes study of 68 institutions. Arch Pathol Lab Med 2007;131:1525-1531. (Pubitemid 47606718)
10. Hong IS, Marshalleck J, Williams RH, Gaiter TE, Mielzynska-Lohnas I, Kim K. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases. Acta Cytol 2002;46:828-834.
11. Levi AW, Kelly DP, Rosenthal DL, Ronnett BM. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: Results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods. Cancer 2003;99:191-197. (Pubitemid 37012909)
12. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1605;281:1605-1610. (Pubitemid 29211769)
13. Solomon D, Schiffman M, Tarone R, Group AS. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299. (Pubitemid 32219816)
14. Renshaw AA, DiNisco SA, Minter LJ, Cibas ES. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process. Cancer 1997;81:272-276. (Pubitemid 28275288)